Navigation Links
Sangamo BioSciences Reports Fourth Quarter and Full Year 2009 Financial Results
Date:2/3/2010

rch Center and Philip Gregory, D. Phil., Sangamo's chief scientific officer and vice president, research  in September 2009. The $486,000 grant, which will be paid over three years, will support an innovative research project conducted by Dr. Kohn and Sangamo scientists and titled "Beta-globin Gene Correction in Hematopoietic Stem Cells for Sickle Cell Disease."
  • California Institute for Regenerative Medicine (CIRM) granted a $14.5 million Disease Team Research Award to develop an AIDS-related lymphoma therapy based on the application of its ZFN gene-editing technology in stem cells. The four year grant supports an innovative research project conducted by a multidisciplinary team of investigators led by John Zaia, M.D. the Aaron D. and Edith Miller Chair in Gene Therapy and chair of virology, City of Hope. The grant application entitled, "Zinc Finger Nuclease-Based Stem Cell Therapy for AIDS," won the highest score of all grants CIRM received in this first round of Disease Team Research Award funding.
  • Sangamo Scientists and Their Collaborators Published Groundbreaking Science in Major Journals:  Published work included the demonstration of ZFN-mediated gene-editing in plant agriculture, transgenic animals, human embryonic and induced pluripotent stem cells and cell lines for the production of protein pharmaceuticals.

  • Business

    • Major Expansion of ZFP Technology License Agreement with Sigma-Aldrich: In October 2009, Sigma-Aldrich Corporation and Sangamo announced a major expansion of their existing license agreement to include the exclusive rights to develop and distribute ZFP-modified cell lines for commercial production of protein pharmaceuticals. Addit
      '/>"/>

    SOURCE Sangamo BioSciences, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

    Related biology technology :

    1. Sangamo BioSciences Announces Presentation at BIO CEO & Investor Conference
    2. Sangamo BioSciences Provides Update on Phase 1 Safety Trial of SB-728-T for HIV/AIDS
    3. Sangamo BioSciences Announces Presentation at Merriman Curhan Fords Investor Summit 2009
    4. Sangamo BioSciences Announces Third Quarter 2009 Conference Call and Webcast
    5. Sangamo Announces Pricing of Public Offering of Common Stock
    6. Sigma-Aldrich(R) and Sangamo BioSciences Announce Major Expansion of ZFP Technology License Agreement
    7. Sangamo BioSciences Announces Presentation at the UBS Global Life Sciences Conference
    8. Sangamos Zinc Finger Nuclease Technology Used to Efficiently Modify Human Stem Cells
    9. Sangamo BioSciences Reports Second Quarter 2009 Financial Results
    10. Sangamo BioSciences Announces Second Quarter 2009 Conference Call and Webcast
    11. Sangamo BioSciences Announces Presentation at the Needham Life Sciences Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/27/2015)... ... , ... Production of high tenacity filament yarn of viscose rayon (excluding sewing ... instance, it surpassed the EUR 106 million mark (in value terms) in 2013, while ... major producer, while Italy is a key consumer. , The high tenacity filament ...
    (Date:7/27/2015)... , July 27, 2015 According ... by Type (Home-brew Media, Pre-formulated Media), by Application (Biobanking, Regenerative ... , Europe , Asia-Pacific ... 2019", The global biopreservation media market was valued at $247.7 ... $571.5 million by 2019, at a CAGR of 18.2% between ...
    (Date:7/26/2015)... (PRWEB) , ... July 26, 2015 , ... ... of its VALIDATE® ANEMIA calibration verification / linearity test kit. The VALIDATE® ANEMIA ... Each VALIDATE® ANEMIA kit is prepared using the CLSI recommended “equal delta” method ...
    (Date:7/24/2015)... , July 24, 2015  Champions Oncology (OTC-BB: CSBR), ... solutions and services to personalize the development and use ... financial and operational results for the fourth quarter and ... July 28, 2015, before market open. The ... results that day at 9:00 a.m. EDT (6:00 a.m. ...
    Breaking Biology Technology:High Tenacity Filament Yarn of Viscose Rayon Consumption to Grow Swiftly in the EU, Forecasts BAC Reports in New Study Available at MarketPublishers.com 2Global Biopreservation Media Market to be Worth $571.5 Million by 2019 2Global Biopreservation Media Market to be Worth $571.5 Million by 2019 3Maine Standards Company, LLC Announces Release of VALIDATE® ANEMIA Calibration Verification / Linearity Test Kit 2Champions Oncology to Announce Fourth Quarter Financial Results on Tuesday, July 28 2
    ... Mass., Oct. 5 Verenium Corporation (Nasdaq: VRNMD ... ethanol and high-performance specialty enzymes, today announced that it ... conditions, shares of its common stock, and potentially warrants, ... expected to price before 9:30 am EDT on Tuesday, ...
    ... ... (NEIRP) has announced it is a sponsor for this year’s 4th Annual Orthopedic Design ... October 6-8, 2009. NEIRP partners and staff will also be available to meet ... the benefits the region has to offer to the medical device industry . ...
    ... Oct. 5 PharmAthene, Inc. (NYSE Amex: ... against biological and chemical threats, today announced that ... Wright and Dr. Valerie Riddle, Vice President and ... Television Channel (HSTV) 30-minute documentary training video entitled, ...
    Cached Biology Technology:Verenium Announces Proposed Public Offering of Common Stock 2Verenium Announces Proposed Public Offering of Common Stock 3Northeast Indiana Regional Partnership to Participate in 2009 Orthopedic Design & Technology Conference & Exhibition 2Northeast Indiana Regional Partnership to Participate in 2009 Orthopedic Design & Technology Conference & Exhibition 3PharmAthene Executives Featured in Anthrax Pathogen Training Video for U.S. Department of Homeland Security 2PharmAthene Executives Featured in Anthrax Pathogen Training Video for U.S. Department of Homeland Security 3
    (Date:7/23/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/rzzp3v/global_outlook_of ) has ... of the Biometrics Industry 2015 " report ... biometrics market is likely to witness significant growth ... the uptake of multiple technologies available. The year ... growth of biometrics in existing applications as well ...
    (Date:7/21/2015)...  NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... on the growing mobile commerce market and creator ... has filed provisional patent 62/192218 for ... This invention highlights next generation payment technology from ... also the user using unique personal identifiers including ...
    (Date:7/20/2015)... 20, 2015  Acuity Market Intelligence,s latest research ... of Commerce and Privacy" forecasts that between 2014 ... will be downloaded to smart mobile devices by ... market is projected to generate more than $67.9 ... seven-year forecast period.    "Biometrics is ...
    Breaking Biology News(10 mins):Global Outlook of the Biometrics Industry 2015 2Global Outlook of the Biometrics Industry 2015 3NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 2NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 3NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 4Biometrics on Smart Mobile Devices to Redefine Digital Identity with 12.9 Billion Biometric App Downloads between 2014 and 2020 2
    ... center called the National Resource for Network Biology (NRNB), ... of Medicine, will help clinicians analyze an ever-growing wealth ... real problems and diseases. In recent years, ... shifting much of their focus from single cells to ...
    ... PORTLAND, Ore. Oregon Health & Science University Doernbecher ... landmark clinical trial to further assess the safety and ... as a potential treatment for infantile or late-infantile neuronal ... disorder that affects infants and children. The Phase ...
    ... 28 October 2010 (Geneva, Switzerland) - A report issued ... Here, Right Now documents the principal debates around ... The report also takes stock of progress to date and ... and prevention at a time when new infections are outstripping ...
    Cached Biology News:New center looks at how human systems function or fail 2New center looks at how human systems function or fail 3OHSU Doernbecher Children's Hospital conducts second phase of landmark Batten study 2New report underlines the threat to universal access to HIV prevention, treatment and care due to a slow-down in treatment scale-up and waning political will 2New report underlines the threat to universal access to HIV prevention, treatment and care due to a slow-down in treatment scale-up and waning political will 3
    ... Yeast Cells are designed for use with ... cerevisiae strain MaV203 contains deletions in the ... with GAL4-based two-hybrid systems. The strain also ... of ProQuest bait and prey vectors. MaV203 ...
    ... designed for use with the ProQuest Two-Hybrid ... contains deletions in the endogenous GAL4 and ... systems. The strain also has leu2 and ... and prey vectors. MaV203 contains three GAL4 ...
    Request Info...
    ... protein in 200 l SDS-PAGE Western blotting buffer, ... transformed macrophage cells, whole cell ... should be stored at -20C and ... sample vial should be boiled once ...
    Biology Products: